Journal of Medical Screening > Volume 15, Number 4 > Pp. 207-210

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tachezy, R. Articles by Dusková, J. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Short Communications

Consensus recommendations for cervical cancer prevention in the Czech Republic: a report of the International Conference on Human Papillomavirus in Human Pathology (Prague, 1–3 May 2008)

Ruth Tachezy  , National Reference Laboratory for Papillomaviruses, Department of Experimental Virology, Institute of Haematology and Blood Transfusion, Prague, Czech Republic

Philip Davies , European Cervical Cancer Association, Brussels, Belgium

Marc Arbyn , Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium; ECCG (European Cooperation on development and implementation of Cancer screening and prevention Guidelines), IARC, Lyon, France

Lukás Rob , Department of Oncogynaecology, Second Medical Faculty, Obstetrics and Gynaecology Clinic, Charles University, Prague, Czech Republic

Gunta Lazdane , WHO Regional Office for Europe, Copenhagen, Denmark

Jana Petrenko , Coalition for Health, Prague, Czech Republic

Eva Hamsíková , National Reference Laboratory for Papillomaviruses, Department of Experimental Virology, Institute of Haematology and Blood Transfusion, Prague, Czech Republic

Alena Beková , Centre of Gynaecology-Oncology Prevention, Prague, Czech Republic

Jan Klozar , Department of Otolaryngology Head and Neck Surgery, First Medical Faculty, Charles University, Prague, Czech Republic

Jaroslava Dusková , Institute of Pathology, First Medical Faculty and Chair of Pathology Institute of Postgraduate Studies, Prague, Czech Republic

Correspondence to: Ruth Tachezy, National Reference Laboratory for Papillomaviruses, Department of Experimental Virology, Institute of Haematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague, Czech Republic; rutach{at}uhkt.cz

---

A comparison of cervical cancer incidence and mortality in the Czech Republic with that from other countries shows that the burden of cervical cancer here is considerably higher than in Western Europe, where screening is widespread. In May 2008, the International Conference on Human Papillomavirus in Human Pathology was convened to review the latest evidence and to formulate consensus recommendations for the reduction of cervical cancer rates. The Czech Republic is spending considerable resources on cervical cancer prevention, but these resources are being used inefficiently. The current system is characterized by a lack of coordination and monitoring that leads to the over-screening of a minority of women while the majority of the target population are under-screened or not screened at all. It was recommended that a comprehensive, organized programme be implemented, coordinated by an independent administrative body with legal and budgetary responsibility. As the laboratory infrastructure and professional technical skills required for a quality-assured organized screening programme are already in place, implementation of this programme would not require much in the way of additional resources to produce substantial cost-effective reductions in cervical cancer rates.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?